“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Related News Articles

Headline
The departments of Health and Human Services, Labor, and the Treasury have certified two more independent dispute resolution entities, bringing the total…
Headline
The latest video in the AHA’s series “Medicaid: Real Lives, Real Care” features Jennifer Clowers, regional chief financial officer of Our Lady of the Lake…
Perspective
Public
The fate of the Trump administration’s legislative centerpiece — the One Big Beautiful Bill Act — continues to be the focal point in Washington, D.C.After the…
Headline
The AHA June 10 released a new video in its series, “Medicaid: Real Lives, Real Care,” that features Missouri Hospital Association President and CEO Jon…
Headline
The White House June 6 issued a memorandum directing the Secretary of the Department of Health and Human Services “to take appropriate action to eliminate…
Headline
A Congressional Budget Office report released June 4 found that enactment of the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act (H…